18th Annual Conference on Peritoneal Dialysis, Tennessee, Amerika Birleşik Devletleri, 23 - 25 Şubat 1998, cilt.14, ss.154-157
In this study, a third-generation cephalosporin with proposed immunomodulatory properties, cefodizime, was investigated to see if it has any effect on the chemotactic activity of human peritoneal monocyte and polymorphonuclear cell populations ex vivo.